Skip to main content

Table 4 Estimated differences between treatments of mean absolute values for lipid parameters across the study period according to the mixed-effects model (mean ± standard error).

From: Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy

  

Cholesterol value

HDL value

LDL value

Total TRG value

  

E-Oa

E-O

E-Oa

E-Oa

Baseline

Mean ± SEM

 

-0.25 ± 1.36

  
 

P

 

0.85

  

6 months

Mean ± SEM

 

-2.96 ± 1.07

  
 

P

 

0.01

  

12 months

Mean ± SEM

-1.23 ± 2.93

-5.68 ± 1.35

7.77 ± 4.42

-0.02 ± 0.03

 

P

0.68

<0.0001

0.08

0.50

18 months

Mean ± SEM

 

-8.39 ± 1.97

  
 

P

 

<0.0001

  

24 months

Mean ± SEM

 

-11.1 ± 2.7

  
 

P

 

<0.0001

  
  1. E = exemestane; O = observation.
  2. aNote: Constant difference between E and O across time.